⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12154036 | 1.00 | — | — | |
| SCHEMBL11934549 | 1.00 | — | — | |
| SCHEMBL10357880 | 1.00 | — | — | |
| SCHEMBL403204 | 1.00 | — | — | |
| SCHEMBL13084557 | 0.84 | — | — | |
| SCHEMBL11934544 | 0.83 | — | — | |
| SCHEMBL10045288 | 0.83 | — | — | |
| SCHEMBL11937053 | 0.83 | — | — | |
| SCHEMBL732693 | 0.83 | — | — | |
| SCHEMBL403118 | 0.82 | CYP2C9 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8209131-B2 | Inflammation, allergic diseases, metastatic cancers, pathogen infections; glycosaminoglycan related molecules | CURTIN UNIVERSITY OF TECHNOLOGY (AU) | 2012-06-26 | — | — | US | disclosed |
| US-8067555-B2 | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect | SIGMA-TAU RESEARCH SWITZERLAND S.A. (CH) | 2011-11-29 | — | — | US | disclosed |
| US-7781416-B2 | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect | SIGMA-TAU RESEARCH SWITZERLAND S.A. (CH) | 2010-08-24 | — | — | US | disclosed |
| US-20100081629-A1 | LOW MOLECULAR WEIGHT HEPARINS INCLUDING AT LEAST ONE COVALENT BOND WITH BIOTIN OR A BIOTIN DERIVATIVE, METHOD FOR MAKING SAME AND USE THEREOF | SANOFI-AVENTIS (FR) | 2010-04-01 | — | — | US | disclosed |
| US-20080139503-A1 | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) | 2008-06-12 | — | — | US | disclosed |
| US-20080051567-A1 | Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect | SIGMA-TAU INDUSTRIE FARMACEUTICHERIUNITE S.P.A. (IT) | 2008-02-28 | — | — | US | disclosed |